Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Stelara for moderate to severely active ulcerative colitis

Sep. 5, 2019

Tonix begins phase I study of TNX-601 for daytime treatment of PTSD

Sep. 5, 2019

First safety data presented from phase II trial of revacept

Sep. 5, 2019

Idera Pharmaceuticals and Abbvie to collaborate on immunooncology trial

Sep. 5, 2019

Optimized liver-directed gene therapy for Pompe's disease evaluated in vivo

Sep. 5, 2019

New CDK7 inhibitors presented by Ancureall Biomedical Technology (Shanghai)

Sep. 5, 2019

Chinese researchers describe BRD4 inhibitors

Sep. 5, 2019

Beijing Scitech-Mq Pharmaceuticals divulges VEGFR2 and MET inhibitors

Sep. 5, 2019

Medshine Discovery presents new ATR kinase inhibitors

Sep. 5, 2019

Ideaya Biosciences patents AhR modulators

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 14, 2025.
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld Science
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld Science
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...